These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 34187274)

  • 1. Axonics® system for treatment of overactive bladder syndrome and urinary urgency incontinence.
    Wang A; Rourke E; Sebesta E; Dmochowski R
    Expert Rev Med Devices; 2021 Aug; 18(8):727-732. PubMed ID: 34187274
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of Urinary Urgency Incontinence Using a Rechargeable SNM System: 6-Month Results of the ARTISAN-SNM Study.
    McCrery R; Lane F; Benson K; Taylor C; Padron O; Blok B; De Wachter S; Pezzella A; Gruenenfelder J; Pakzad M; Perrouin-Verbe MA; Le Normand L; Van Kerrebroeck P; Mangel J; Peters K; Kennelly M; Shapiro A; Lee U; Comiter C; Mueller M; Goldman HB
    J Urol; 2020 Jan; 203(1):185-192. PubMed ID: 31347955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review of the rechargeable sacral neuromodulation system to treat refractory overactive bladder.
    Albabtain M; Chughtai B; Cho A; Elterman D
    Ther Deliv; 2021 May; 12(5):353-362. PubMed ID: 33821666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two-year outcomes of the ARTISAN-SNM study for the treatment of urinary urgency incontinence using the Axonics rechargeable sacral neuromodulation system.
    Pezzella A; McCrery R; Lane F; Benson K; Taylor C; Padron O; Blok B; de Wachter S; Gruenenfelder J; Pakzad M; Perrouin-Verbe MA; van Kerrebroeck P; Mangel J; Peters K; Kennelly M; Shapiro A; Lee U; Comiter C; Mueller M; Goldman HB
    Neurourol Urodyn; 2021 Feb; 40(2):714-721. PubMed ID: 33508155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two-year safety and efficacy outcomes for the treatment of overactive bladder using a long-lived rechargeable sacral neuromodulation system.
    Blok B; Van Kerrebroeck P; de Wachter S; Ruffion A; Van der Aa F; Perrouin-Verbe MA; Elneil S
    Neurourol Urodyn; 2020 Apr; 39(4):1108-1114. PubMed ID: 32243625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. One-year outcomes of the ARTISAN-SNM study with the Axonics System for the treatment of urinary urgency incontinence.
    Benson K; McCrery R; Taylor C; Padron O; Blok B; de Wachter S; Pezzella A; Gruenenfelder J; Pakzad M; Perrouin-Verbe MA; Van Kerrebroeck P; Mangel J; Peters K; Kennelly M; Shapiro A; Lee U; Comiter C; Mueller M; Goldman H; Lane F
    Neurourol Urodyn; 2020 Jun; 39(5):1482-1488. PubMed ID: 32339339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Five-Year Followup Results of a Prospective, Multicenter Study of Patients with Overactive Bladder Treated with Sacral Neuromodulation.
    Siegel S; Noblett K; Mangel J; Bennett J; Griebling TL; Sutherland SE; Bird ET; Comiter C; Culkin D; Zylstra S; Kan F; Berg KC
    J Urol; 2018 Jan; 199(1):229-236. PubMed ID: 28709886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The novel Axonics® rechargeable sacral neuromodulation system: Procedural and technical impressions from an initial North American experience.
    Elterman DS
    Neurourol Urodyn; 2018 Feb; 37(S2):S1-S8. PubMed ID: 29336078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three month clinical results with a rechargeable sacral neuromodulation system for the treatment of overactive bladder.
    Blok B; Van Kerrebroeck P; de Wachter S; Ruffion A; Van der Aa F; Jairam R; Perrouin-Verbe M; Elneil S
    Neurourol Urodyn; 2018 Feb; 37(S2):S9-S16. PubMed ID: 29315785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unilateral versus bilateral sacral neuromodulation test in the treatment of refractory idiopathic overactive bladder: A randomized controlled pilot trial.
    Wagner L; Alonso S; Le Normand L; Faix A; Kabani S; Castelli C; Gamé X; Cornu JN; Bey E
    Neurourol Urodyn; 2020 Nov; 39(8):2230-2237. PubMed ID: 32835443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results of a prospective, multicenter study evaluating quality of life, safety, and efficacy of sacral neuromodulation at twelve months in subjects with symptoms of overactive bladder.
    Noblett K; Siegel S; Mangel J; Griebling TL; Sutherland SE; Bird ET; Comiter C; Culkin D; Bennett J; Zylstra S; Kan F; Berg KC
    Neurourol Urodyn; 2016 Feb; 35(2):246-51. PubMed ID: 25546568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. OnabotulinumtoxinA vs Sacral Neuromodulation on Refractory Urgency Urinary Incontinence in Women: A Randomized Clinical Trial.
    Amundsen CL; Richter HE; Menefee SA; Komesu YM; Arya LA; Gregory WT; Myers DL; Zyczynski HM; Vasavada S; Nolen TL; Wallace D; Meikle SF
    JAMA; 2016 Oct; 316(13):1366-1374. PubMed ID: 27701661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Refractory urgency urinary incontinence treatment in women: impact of age on outcomes and complications.
    Komesu YM; Amundsen CL; Richter HE; Erickson SW; Ackenbom MF; Andy UU; Sung VW; Albo M; Gregory WT; Paraiso MF; Wallace D;
    Am J Obstet Gynecol; 2018 Jan; 218(1):111.e1-111.e9. PubMed ID: 29031894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Axonics Sacral Neuromodulation System for Treating Refractory Overactive Bladder: A NICE Medical Technologies Guidance.
    Poole RL; Dale M; Morgan H; Oladapo T; Brookfield R; Morris R
    Appl Health Econ Health Policy; 2022 May; 20(3):305-313. PubMed ID: 34964090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initial experience using the Axonics sacral neuromodulation system in patients with multiple sclerosis.
    Chen A; Kapur A; Mossack S; Weissbart SJ; Kim JM
    Neurourol Urodyn; 2022 Aug; 41(6):1373-1379. PubMed ID: 35579263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of electrical stimulation techniques in the management of the male patient with urgency incontinence.
    Johnsen NV; Osborn DJ; Dmochowski RR
    Curr Opin Urol; 2014 Nov; 24(6):560-5. PubMed ID: 25144143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific Changes in Brain Activity during Urgency in Women with Overactive Bladder after Successful Sacral Neuromodulation: A Functional Magnetic Resonance Imaging Study.
    Weissbart SJ; Bhavsar R; Rao H; Wein AJ; Detre JA; Arya LA; Smith AL
    J Urol; 2018 Aug; 200(2):382-388. PubMed ID: 29630979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flat Magnetic Stimulation for Urge Urinary Incontinence.
    Barba M; Cola A; Rezzan G; Costa C; Re I; Volontè S; Terzoni S; Frigerio M; Maruccia S
    Medicina (Kaunas); 2023 Nov; 59(11):. PubMed ID: 38004048
    [No Abstract]   [Full Text] [Related]  

  • 19. A prospective, multicenter study of a novel, miniaturized rechargeable sacral neuromodulation system: 12-month results from the RELAX-OAB study.
    Blok B; Van Kerrebroeck P; de Wachter S; Ruffion A; Van der Aa F; Jairam R; Perrouin-Verbe MA; Elneil S
    Neurourol Urodyn; 2019 Feb; 38(2):689-695. PubMed ID: 30592526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the axonics modulation technologies sacral neuromodulation system for the treatment of urinary and fecal dysfunction.
    Cohn JA; Kowalik CG; Kaufman MR; Reynolds WS; Milam DF; Dmochowski RR
    Expert Rev Med Devices; 2017 Jan; 14(1):3-14. PubMed ID: 27915486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.